Amedisys Inc (AMED) Shares are Down -3.58%

Amedisys Inc (AMED) : During the past 4 weeks, traders have been relatively bearish on Amedisys Inc (AMED), hence the stock is down -12.62% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -3.55% relative to the S&P 500. The 4-week change in the price of the stock is -12.28% and the stock has fallen -3.58% in the past 1 week.

Amedisys Inc. has dropped 7.04% during the last 3-month period . Year-to-Date the stock performance stands at 19.18%. The stock has recorded a 20-day Moving Average of 7.86% and the 50-Day Moving Average is 7.95%.


Amedisys Inc (NASDAQ:AMED): The stock opened at $47.58 on Friday but the bulls could not build on the opening and the stock topped out at $47.58 for the day. The stock traded down to $46.74 during the day, due to lack of any buying support eventually closed down at $46.86 with a loss of -2.17% for the day. The stock had closed at $47.90 on the previous day. The total traded volume was 337,312 shares.

Also, Equity analysts at the Brokerage firm Mizuho Securities downgrades its rating on Amedisys Inc (NASDAQ:AMED). The rating major has initiated the coverage with neutral rating on the shares. Earlier, the shares were rated a Buy by the brokerage firm. The rating by the firm was issued on August 3, 2016.

Amedisys, Inc. (Amedisys) is a health care at home company. Amedisys delivers home health and hospice care to more than 360,000 patients each year. The Company has care network across 34 states. As of December 31, 2014, it owned and operated 316 Medicare-certified home health care centers and 80 Medicare-certified hospice care centers. The Company operates through two segments: home health and hospice. The Companys home health segment delivers a range of services in the homes of individuals who may be recovering from surgery, have a chronic disability or terminal illness or need assistance with the essential activities of daily living. The Companys hospice segment provides palliative care and comfort to terminally ill patients and their families.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.